Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading Up 0.4% – What’s Next?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) shares shot up 0.4% during mid-day trading on Friday . The stock traded as high as $10.65 and last traded at $10.65. 225,508 shares were traded during trading, an increase of 586% from the average session volume of 32,893 shares. The stock had previously closed at $10.61.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Oaktree Acquisition Corp. III Life Sciences presently has an average rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Price Performance

The company has a 50-day simple moving average of $10.61 and a 200 day simple moving average of $10.54.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OACC. Clear Street Group Inc. bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the 3rd quarter valued at $231,000. Clear Street LLC boosted its position in Oaktree Acquisition Corp. III Life Sciences by 265.1% during the second quarter. Clear Street LLC now owns 22,000 shares of the company’s stock valued at $230,000 after purchasing an additional 15,975 shares in the last quarter. Readystate Asset Management LP purchased a new position in Oaktree Acquisition Corp. III Life Sciences in the third quarter valued at about $262,000. Meteora Capital LLC bought a new position in Oaktree Acquisition Corp. III Life Sciences in the second quarter worth about $517,000. Finally, Radcliffe Capital Management L.P. bought a new position in Oaktree Acquisition Corp. III Life Sciences in the second quarter worth about $856,000.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.